Table V.
Terminal nodea | Cases/controlsb | Case rate (%) | Adjusted ORc | P-value |
1 | 23/53 | 30.26 | Ref. | |
2 | 8/18 | 30.77 | 1.25 (0.45–3.41) | 0.67 |
3 | 18/16 | 52.94 | 3.92 (1.62–9.48) | 0.002 |
4 | 19/31 | 38.00 | 1.79 (0.81–3.98) | 0.15 |
5 | 43/38 | 53.09 | 3.31 (1.62–6.76) | 0.001 |
6 | 25/29 | 46.30 | 2.41 (1.11–5.25) | 0.03 |
7 | 25/14 | 64.10 | 5.67 (2.34–13.74) | <0.001 |
8 | 39/46 | 45.88 | 2.39 (1.19–4.82) | 0.01 |
9 | 37/18 | 67.27 | 6.37 (2.86–14.19) | <0.001 |
10 | 23/8 | 74.19 | 7.63 (2.84–20.50) | <0.001 |
Refer to Figure 1 for definition of each terminal node.
The total number of cases and controls does not add up to 325 and 335, respectively, because only subjects without missing SNP data were included in the analysis.
Adjusted for age, gender, smoking status, hypertension and body mass index.